Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

20.71
+0.33501.64%
Volume:576.55K
Turnover:11.92M
Market Cap:1.80B
PE:-5.75
High:21.06
Open:20.36
Low:20.34
Close:20.37
52wk High:21.22
52wk Low:8.58
Shares:86.91M
Float Shares:72.72M
Volume Ratio:0.47
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6004
EPS(LYR):-3.7228
ROE:-129.32%
ROA:-39.24%
PB:15.59
PE(LYR):-5.56

Loading ...

OverviewCompanyNewsFilings

Syndax Pharmaceuticals Inc. to Announce Second Quarter 2025 Financial Results

Reuters
·
Jul 28

Syndax Pharmaceuticals Inc. CEO Michael A. Metzger Reports Disposal of Common Shares

Reuters
·
Jul 19

CFO Keith A. Goldan Reports Disposal of Common Shares in Syndax Pharmaceuticals Inc

Reuters
·
Jul 19

UBS Adjusts Price Target on Syndax Pharmaceuticals Inc to $35 From $37, Maintains Buy Rating

MT Newswires Live
·
Jul 15

Syndax Pharmaceuticals Initiated at Buy by Goldman Sachs

Dow Jones
·
Jul 10

Syndax Pharmaceuticals Unveils New Inducement Plan, Grants Stock Options to 14 New Employees

Reuters
·
Jul 03

William Meury Resigns from Syndax Pharmaceuticals Board to Join Incyte Corporation as CEO

Reuters
·
Jun 26

Syndax Gets US FDA Priority Review of Supplemental New Drug Application for Revuforj in Acute Myeloid Leukemia

MT Newswires Live
·
Jun 25

Syndax Pharmaceuticals Announces Promising Results from BEAT AML Trial with Revumenib at EHA 2025, Highlighting Potential Cornerstone Therapy for Acute Leukemias

Reuters
·
Jun 13

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Nov 03, 2025 Post Market
Financial Report Announcement
Aug 04, 2025 Post Market
Financial Report Announcement
May 05, 2025 Post Market
Financial Report Announcement
Mar 03, 2025 Pre-Market
Financial Report Announcement
Nov 05, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-5.75
Current
73.78
Sector Average
62.47%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-5.75
Maximum
1,702.49
+1 STD
437.13
Minimum
-137.41
-1 STD
-289.58
Average
73.78

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.